180 related articles for article (PubMed ID: 3839411)
1. Orbital rhabdomyosarcoma: improved survival with combined pulsed chemotherapy and irradiation.
Ghafoor SY; Dudgeon J
Br J Ophthalmol; 1985 Aug; 69(8):557-61. PubMed ID: 3839411
[TBL] [Abstract][Full Text] [Related]
2. The treatment of orbital rhabdomyosarcoma with irradiation and chemotherapy.
Abramson DH; Ellsworth RM; Tretter P; Wolff JA; Kitchin FD
Ophthalmology; 1979 Jul; 86(7):1330-5. PubMed ID: 233865
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary.
Orbach D; Brisse H; Helfre S; Freneaux P; Husseini K; Aerts I; Desjardins L; Fattet S
Expert Opin Pharmacother; 2003 Dec; 4(12):2165-74. PubMed ID: 14640915
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of orbital rhabdomyosarcoma in two infants using chemotherapy alone.
Lackner H; Urban C
Med Pediatr Oncol; 1997 Jun; 28(6):463-4. PubMed ID: 9143395
[No Abstract] [Full Text] [Related]
5. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
Gandhi PD; Fleming JC; Haik BG; Wilson MW
Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
[TBL] [Abstract][Full Text] [Related]
6. Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma.
Smith SC; Lindsley SK; Felgenhauer J; Hawkins DS; Douglas JG
J Pediatr Hematol Oncol; 2003 Oct; 25(10):774-9. PubMed ID: 14528099
[TBL] [Abstract][Full Text] [Related]
7. Radiation and chemotherapy of parameningeal rhabdomyosarcoma involving the orbit.
Haik BG; Jereb B; Smith ME; Ellsworth RM; McCormick B
Ophthalmology; 1986 Aug; 93(8):1001-9. PubMed ID: 3763144
[TBL] [Abstract][Full Text] [Related]
8. [Update of orbital rhabdomyosarcoma therapy in children].
Ducrey N; Nenadov-Beck M; Spahn B
J Fr Ophtalmol; 2002 Mar; 25(3):298-302. PubMed ID: 11941256
[TBL] [Abstract][Full Text] [Related]
9. Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.
Boutroux H; Cellier C; Mosseri V; Helfre S; Levy C; Desjardins L; Plancher C; Freneaux P; Michon J; Orbach D
J Pediatr Hematol Oncol; 2014 Nov; 36(8):605-12. PubMed ID: 25171453
[TBL] [Abstract][Full Text] [Related]
10. [Primary rhabdomyosarcoma of the temporal bone].
Lorenzo Núñez R; Ramos Benavente MD; Morales Jiménez C; Ruiz Medina E
Acta Otorrinolaringol Esp; 1995; 46(1):53-6. PubMed ID: 7734166
[TBL] [Abstract][Full Text] [Related]
11. Management of embryonal rhabdomyosarcoma in children.
Exelby PR
Surg Clin North Am; 1974 Aug; 54(4):849-57. PubMed ID: 4610841
[No Abstract] [Full Text] [Related]
12. Rhabdomyosarcoma of the ear and temporal bone.
Wiatrak BJ; Pensak ML
Laryngoscope; 1989 Nov; 99(11):1188-92. PubMed ID: 2811561
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma.
Paulino AC; Simon JH; Zhen W; Wen BC
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1489-95. PubMed ID: 11121653
[TBL] [Abstract][Full Text] [Related]
14. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Ermoian RP; Breneman J; Walterhouse DO; Chi YY; Meza J; Anderson J; Hawkins DS; Hayes-Jordan AA; Parham DM; Yock TI; Donaldson SS; Wolden SL
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28548706
[TBL] [Abstract][Full Text] [Related]
15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4-2004. A nine-month-old boy with an orbital rhabdomyosarcoma.
Friedmann AM; Tarbell NJ; Schaefer PW; Hoch BL
N Engl J Med; 2004 Jan; 350(5):494-502. PubMed ID: 14749459
[No Abstract] [Full Text] [Related]
16. Modern treatment of vaginal embryonal rhabdomyosarcoma.
Friedman M; Peretz BA; Nissenbaum M; Paldi E
Obstet Gynecol Surv; 1986 Oct; 41(10):614-8. PubMed ID: 3534662
[No Abstract] [Full Text] [Related]
17. Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography.
Fusner JE; Poplack DG; Pizzo PA; Di Chiro G
J Pediatr; 1977 Jul; 91(1):77-9. PubMed ID: 874669
[No Abstract] [Full Text] [Related]
18. Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Weigel BJ; Lyden E; Anderson JR; Meyer WH; Parham DM; Rodeberg DA; Michalski JM; Hawkins DS; Arndt CA
J Clin Oncol; 2016 Jan; 34(2):117-22. PubMed ID: 26503200
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for rhabdomyosarcoma of the orbit.
Sagerman RH; Cassady JR; Tretter P
Trans Am Acad Ophthalmol Otolaryngol; 1968; 72(6):849-54. PubMed ID: 4177896
[No Abstract] [Full Text] [Related]
20. Response of orbital and central nervous system metastases of retinoblastoma following treatment with cyclophosphamide/doxorubicin.
Pratt CB; Kun LE
Pediatr Hematol Oncol; 1987; 4(2):125-30. PubMed ID: 3152919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
